Hikma Pharmaceuticals Usa INC.
UEI NQJ5E87TKNB1 CAGE 32655 Active Berkeley Heights, NJ
Other Than Small Business · Data through September 30, 2026
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2026 | $7.5M |
| FY2025 | $567K |
| FY2024 | $43K |
| FY2023 | $345K |
| FY2022 | $861K |
| FY2021 | $308K |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Health and Human Services | $7.5M | 77.8% |
| Department of Defense | $2.1M | 21.5% |
| Department of Veterans Affairs | $65K | 0.7% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $7.6M | 78.5% |
| 325411 — Medicinal and Botanical Manufacturing | $2.1M | 21.5% |
| PSC code | Obligations | Share |
|---|---|---|
| 6505 — Drugs and Biologicals | $9.6M | 99.6% |
| 6515 — Medical and Surgical Instruments, Equipment, and Supplies | $42K | 0.4% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $9.7M | 100% |
| Set-aside type | Obligations | Share |
|---|---|---|
| No Set Aside Used. | $7.5M | 77.8% |
| Not Specified | $2.1M | 22.2% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| GA | $7.5M | 77.8% |
| NJ | $2.1M | 22.2% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| 75A50326C00012 · NAICS 325412 | Department of Health and Human Services | September 30, 2026 – September 29, 2027 | $7.5M | View on USAspending |
| SPE2D021F0295 · NAICS 325411 | Department of Defense | July 6, 2021 – July 12, 2022 | $295K | View on USAspending |
| SPE2D325F344A · NAICS 325411 | Department of Defense | August 25, 2025 – August 26, 2025 | $237K | View on USAspending |
| SPE2D325F343Z · NAICS 325411 | Department of Defense | August 25, 2025 – August 26, 2025 | $163K | View on USAspending |
| SPE2D322F427G · NAICS 325411 | Department of Defense | August 19, 2022 – August 24, 2022 | $153K | View on USAspending |
| SPE2D322F427L · NAICS 325411 | Department of Defense | August 19, 2022 – August 24, 2022 | $136K | View on USAspending |
| SPE2D322F427M · NAICS 325411 | Department of Defense | August 19, 2022 – August 24, 2022 | $119K | View on USAspending |
| SPE2D322F427F · NAICS 325411 | Department of Defense | August 19, 2022 – August 24, 2022 | $102K | View on USAspending |
| SPE2D023F0487 · NAICS 325411 | Department of Defense | July 10, 2023 – August 6, 2024 | $93K | View on USAspending |
| SPE2D325F214Z · NAICS 325411 | Department of Defense | July 14, 2025 – July 15, 2025 | $84K | View on USAspending |
Parent company
Hikma Specialty Usa INC (UEI CH1CEGU3DW33)
Similar contractors
- Takeda Pharmaceuticals America, INC. — $10.5M, Cambridge, MA
- Priority Healthcare Distribution INC — $18.0M, Lake Mary, FL
- Jubilant Draximage Radiopharmacies, INC. — $19.8M, Norcross, GA
- Medi-Physics, INC. — $20.5M, Marlborough, MA
- Bracco Diagnostics INC. — $20.9M, Princeton, NJ
- Bristol-Myers Squibb COMPANY — $22.2M, Lawrenceville, NJ
- Bayer Healthcare Pharmaceuticals INC — $26.3M, Whippany, NJ
- Nationwide Pharmaceutical LLC — $26.9M, San Antonio, TX
What the numbers show
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Obligations increased from $567K in FY2025 to $7.5M in FY2026, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2026, downloaded 2026-10-21. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.